Virologic Failures on Initial Boosted-PI Regimen Infrequently Possess Low-Level Variants with Major PI Resistance Mutations by Ultra-Deep Sequencing

BACKGROUND: It is unknown whether HIV-positive patients experiencing virologic failure (VF) on boosted-PI (PI/r) regimens without drug resistant mutations (DRM) by standard genotyping harbor low-level PI resistant variants. CASTLE compared the efficacy of atazanavir/ritonavir (ATV/r) with lopinavir/...

Descripción completa

Detalles Bibliográficos
Autores principales: Lataillade, Max, Chiarella, Jennifer, Yang, Rong, DeGrosky, Michelle, Uy, Jonathan, Seekins, Daniel, Simen, Birgitte, St. John, Elizabeth, Moreno, Elizabeth, Kozal, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280244/
https://www.ncbi.nlm.nih.gov/pubmed/22355307
http://dx.doi.org/10.1371/journal.pone.0030118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280244/
https://www.ncbi.nlm.nih.gov/pubmed/22355307
http://dx.doi.org/10.1371/journal.pone.0030118

Ejemplares similares